The effect of cellex on the recovery of motor and speech functions during early neurorehabilitation of patients with ischemic stroke
https://doi.org/10.21518/2079-701X-2018-9-14-19
Abstract
The results of the evaluation of a сellex drug effect on dynamics of a neurologic deficit regression in an acute ischemic stroke in patients with movement disorders and aphathic disorders are presented. 40 patients aged from 47 to 84 years, including 24 women and 16 men, in acute ischemic stroke with the development of motor and aphathic disorders were examined. Based on the results of the study, it was concluded that the early use of the drug сellex in complex therapy in the treatment of patients in the acute period of ischemic stroke with aphathic and motor disorders is effective. The drug helps to increase the effectiveness of logopedic exercises, non-drug methods of motor function recovery, thereby increasing the rehabilitation potential.
About the Authors
D. P. Khasanova
Kazan State Medical University of the Ministry of Health of Russia; Interreginal Clinical Diagnostic Center
Russian Federation
Russian Federation
T. V. Danilova
Kazan State Medical University of the Ministry of Health of Russia; Interreginal Clinical Diagnostic Center
Russian Federation
Russian Federation
T. V. Demin
Kazan State Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
K. S. Knni
Kazan State Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
L. V. Gaifutdinova
Kazan State Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
References
1. Isaikin AI, Kuznetsov IV, Kavelina AV. Nonspecific lumbalgia: causes, clinical picture, diagnosis, treatment. Nevrologiya, Neyropsihiatriya, Psikhosomatika, 2015, 7 (4): 101-109.
2. Karateev AE, Nasonov EL, Yakhno NN, et al. Clinical guidelines: rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice. Sovremennaya Revmatologiya, 2015, 1: 4-23.
3. Parfenov VA, Gerasimova ON Management of patients with back pain in outpatient practice. Nevrologiya, Neyropsihiatriya, Psikhosomatika, 2010, 2 (4): 65-71.
4. Parfenov VA. Causes, diagnosis and treatment of lower back pain. Nevrologiya, Neyropsihiatriya, Psikhosomatika, 2009, 1: 19-22.
5. Parfenov VA. Diagnosis and treatment of acute lower back pain. RMJ, 2007, 15 (6): 507-510.
6. Podchufarova EV, Yakhno NN. Back pain. Moscow: GEOTAR-Media, 2013. 368 p.
7. Podchufarova EV. Back pain treatment. Nevrologiya, Neyropsihiatriya, Psikhosomatika, 2009, 2: 29-36.
8. Podchufarova EV. Mechanisms in the development and treatment of back pain. Sovremennaya Terapiya v Psihiatrii I Nevrologii, 2012, 3: 47-54.
9. Beltran J, Martin-Mola E, Figuero M et al. Comparison of Dexketoprofen Trometamol and Ketoprofen in the treatment of osteoarthritis of the knee. J Clin Pharm, 1998, 38: 74–80.
10. Clark DW, Layton D, Shakir SA. Do some inhibitors of COX-2 increase the risk of thromboembolic events? Linking pharmacology with pharmacoepidemiology. Drug Saf, 2004, 27(7): 427-56.
11. Goubert D, Van Oosterwijck J, Mira Meeus M, Danneels L. Structural Changes of Lumbar Muscles in Non-Specific Low Back Pain. Pain Physician, 2016, 19: E985-E1000.
12. Hayden JA, van Tulder MW, Malmivaara A et al. Exercise therapy for treatment of non-specific low back pain. Cochrane database Syst Rev, 2005, Jul 20, 3: CD000335.
13. Kuritzky L, Samraj GP. Nonsteroidal anti-inflammatory drugs in the treatment of low back pain. J Pain Res, 2012, 5: 579–590.
14. Rossignol M, Arsenault B, Dionne C et al. Clinic on low-back pain in interdisciplinary practice (clip) guidelines. 2007. http://www.santpub-mtl.qc.ca/clip.
15. van Tulder M, Becker А, Bekkering T et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J, 2006, 15(Suppl. 2): 169-91.
Review
For citations:
Khasanova DP, Danilova TV, Demin TV, Knni KS, Gaifutdinova LV. The effect of cellex on the recovery of motor and speech functions during early neurorehabilitation of patients with ischemic stroke. Meditsinskiy sovet = Medical Council. 2018;(9):14-19. (In Russ.) https://doi.org/10.21518/2079-701X-2018-9-14-19
Views:
766
Email this article 